Drug profile · INN
dexlansoprazole
DEXLANSOPRAZOLE
dexlansoprazole (DEXLANSOPRAZOLE) is a potassium-transporting atpase inhibitor. Associated with Takeda. Route of administration: oral. Current US regulatory status: approved.
Drug details — dexlansoprazole
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 15
- Programs
- 22
- Data quality
- 0.89
Quick answer
dexlansoprazole (DEXLANSOPRAZOLE) is a potassium-transporting atpase inhibitor. Associated with Takeda. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Potassium-transporting ATPase inhibitor
Primary target: Potassium-transporting ATPase
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Related patents
-
US 9241910
Orally-disintegrating solid preparation
granted -
US 9238029
Multiple PPI dosage form
granted -
US 9233103
Methods for treating heartburn, gastric bleeding or hemorrhage in patients receiving clopidogrel therapy
granted -
US 9114085
Modified release pharmaceutical compositions of dexlansoprazole
granted -
US 9011926
Method for producing granules
granted -
US 8871273
Method for producing granules
granted -
US 8758818
Oral tablet compositions of dexlansoprazole
granted -
US 8753682
Dual release oral tablet compositions of dexlansoprazole
granted -
US 8741345
Modified release pharmaceutical compositions of dexlansoprazole
granted -
US 8563035
Oral tablet compositions of dexlansoprazole
granted -
US 8563034
Dual release oral tablet compositions of dexlansoprazole
granted -
US 8461187
Multiple PPI dosage form
granted -
US 8173158
Methods of treating gastrointestinal disorders independent of the intake of food
granted -
US 8105626
Granules containing acid-unstable chemical in large amount
granted -
US 7790755
Controlled release preparation
granted
Frequently asked questions
What is dexlansoprazole?
dexlansoprazole (DEXLANSOPRAZOLE) is a potassium-transporting atpase inhibitor. Associated with Takeda. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for dexlansoprazole?
DEXLANSOPRAZOLE is a marketed brand name for dexlansoprazole. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of dexlansoprazole?
dexlansoprazole has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.